Skip to main content

Table 5 Interventions against HIV/AIDS and their associated coverage levels, total costs, yearly costs, yearly infections averted, yearly DALYS averted and sorted by average cost effectiveness

From: Determining a cost effective intervention response to HIV/AIDS in Peru

Intervention

Coverage level (%)

Total costs ($ Millions) 2008-2013

Yearly costs ($ Millions)

Total infections averted (2008-2013)

Yearly infections averted

Yearly DALYS averted

Average cost effectiveness - $/DALY averted (range*)

FSW

50

0.6

0.1

1,970

394

10,118

55 (2 - 124)

FSW

95

1.0

0.2

3,730

746

19,157

55 (1 - 105)

FSW

80

0.9

0.1

3,130

626

16,076

55 (2 - 116)

Blood safety

50

5.3

0.9

13,050

2,610

67,025

79 (41 - 79)

Blood safety

80

8.5

1.4

20,570

4,114

105,648

80 (43 - 80)

Blood safety

95

10.1

1.7

24,260

4,852

124,599

81 (43 - 91)

VCT

95

8.2

1.4

13,870

2,774

71,236

116 (18 - 116)

VCT

50

4.4

0.7

7,300

1,460

37,493

118 (18 - 118)

VCT

80

7.1

1.2

11,670

2,334

59,937

118 (18 - 118)

Youth: in-school

50

13.7

2.3

21,760

4,352

131,126

104 (12 - 177)

Youth: in-school

80

22.0

3.7

22,760

4,552

137,152

161 (19 - 270)

Youth: in-school

95

26.2

4.4

23,020

4,604

138,719

189 (12 - 630)

mass media

50

11.3

1.9

8,930

1,786

45,864

246 (89 - 253)

Condoms

95

61.0

10.2

23,740

4,748

121,929

500 (64 - 500)

Condoms

80

51.3

8.6

19,890

3,978

102,155

503 (62 - 503)

Condoms

50

32.1

5.3

12,430

2,486

63,840

503 (58 - 503)

STI treatment

50

25.1

4.2

6,600

1,320

33,898

739 (200 - 1021)

STI treatment

80

40.1

6.7

10,290

2,058

52,849

759 (199 - 1045)

STI treatment

95

47.6

7.9

12,080

2,416

62,043

767 (200 - 1055)

MSM

50

75.0

12.5

11,090

2,218

56,958

1,317 (354 - 1317)

MSM

80

120.0

20.0

17,570

3,514

90,240

1,330 (351 - 1330)

MSM

95

142.5

23.8

20,770

4,154

106,675

1,336 (350 - 1336)

HAART

       

   Comprehensive

95

37.7

6.3

-

-

18917

1995

   Intermediate

95

37.7

6.3

-

-

16412

2297

   Basic

95

33.6

5.6

-

-

13999

2403

PMTCT

80

246.4

41.1

10,460

2092

41,557

5,928 (2313 - 5.928)

  1. *Ranges based upon sensitivity analysis whereby the model was run using randomly generated values for the behavioural and biological parameters which were varied so that HIV prevalence rates did not deviate by greater than 50% from the baseline predictions.